Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be

Laura Lasagni1, Maria Lucia Angelotti1, Elisa Ronconi2

  • 1Excellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Stem Cell Reports
|August 4, 2015
PubMed

Insights

Renal progenitor cells are key to kidney disease recovery. Enhancing their differentiation into podocytes can promote remission in chronic kidney disease, offering a potential therapeutic strategy.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Glomerular Biology

Background:

  • Podocyte loss is a primary driver of chronic kidney disease (CKD) progression, affecting 10% of the global population.
  • The role of regenerative responses, specifically podocyte regeneration, in determining CKD outcomes remains incompletely understood.

Purpose of the Study:

  • To investigate the influence of regenerative responses to podocyte injury on the progression and remission of chronic kidney disease.
  • To identify the role of renal progenitors in podocyte regeneration and their impact on glomerular disease outcome.

Main Methods:

  • Utilized inducible transgenic mouse models with tagged podocytes and renal progenitors to study focal segmental glomerulosclerosis (FSGS).
  • Assessed disease remission or progression based on the extent of podocyte regeneration and renal progenitor differentiation.
  • Administered BIO, a GSK3 inhibitor, to evaluate its effect on renal progenitor differentiation and disease remission.

Main Results:

  • In FSGS models, disease remission correlated directly with the number of regenerated podocytes.
  • When renal progenitors were tagged, successful differentiation into podocytes led to disease remission, whereas ineffective differentiation resulted in persistent glomerulosclerosis.
  • Treatment with BIO significantly enhanced disease remission by improving renal progenitor differentiation.

Conclusions:

  • Renal progenitors are critical determinants of chronic kidney disease outcomes.
  • Pharmacological enhancement of renal progenitor differentiation represents a promising therapeutic strategy for managing glomerular diseases.

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
9.2K
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
6.5K
Drug Elimination by Renal Route: Glomerular Filtration01:17

Drug Elimination by Renal Route: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
7.8K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.8K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
549
Renal Drug Excretion: Glomerular Filtration01:02

Renal Drug Excretion: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
1.8K